Global Pyelonephritis Drug Market Study 2016-2026, by Segment (Finafloxacin, Fosfomycin Tromethamine, … …), by Market (Hospital, Clinic, … …), by Company (Achaogen Inc, AstraZeneca Plc, … …)
SKU ID :99ST-14631879 | Published Date: 29-Oct-2019 | No. of pages: 52Description
Summary
The global Pyelonephritis Drug market will reach Volume Million USD in 2019 and with a CAGR xx% between 2020-2026.
Finafloxacin
Fosfomycin Tromethamine
Nacubactam
Plazomicin Sulfate
Others
Demand Coverage (Market Size & Forecast, Consumer Distribution):
Hospital
Clinic
Others
Achaogen Inc
AstraZeneca Plc
Meiji Seika Pharma Co Ltd
Merck & Co Inc
MerLion Pharmaceuticals Pte Ltd
The Medicines Company
Zavante Therapeutics Inc
North America
Europe
Asia-Pacific
South America
Middle East & Africa
The global Pyelonephritis Drug market will reach Volume Million USD in 2019 and with a CAGR xx% between 2020-2026.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Finafloxacin
Fosfomycin Tromethamine
Nacubactam
Plazomicin Sulfate
Others
Demand Coverage (Market Size & Forecast, Consumer Distribution):
Hospital
Clinic
Others
Company Coverage (Sales data, Main Products & Services etc.):
Achaogen Inc
AstraZeneca Plc
Meiji Seika Pharma Co Ltd
Merck & Co Inc
MerLion Pharmaceuticals Pte Ltd
The Medicines Company
Zavante Therapeutics Inc
Major Region
MarketNorth America
Europe
Asia-Pacific
South America
Middle East & Africa
TOC
Tables & Figures
Companies
- PRICE
-
$1800$3600Buy Now